Table 2 Association between peer victimisation and somatic symptoms

0

48.7

1.00

38.6

1.00

1-2

56.9

1.44 (1.15-1.81)^b

42.9

1.21 (0.83-1.75)

3-5

61.3

1.81 (1.42-2.31)^c

47.6

1.44 (1.04-1.99)^a

6-8

65.5

2.27 (1.65-3.11)^c

54.0

1.80 (1.22-2.65)^b

9-10

67.2

2.33 (1.31-4.14)^b

66.7

3.25 (2.38-4.43)^c

11-27

79.4

4.46 (2.51-7.94)^c

57.1

2.04 (1.15-3.62)^a

0

30.2

1.00

23.2

1.00

1-2

36.5

1.34 (1.06-1.70)^a

20.4

0.85 (0.59-1.23)

3-5

43.2

1.85 (1.56-2.21)^c

29.6

1.40 (0.94-2.08)

6-8

44.4

2.00 (1.45-2.77)^c

35.8

1.79 (1.31-2.45)^c

9-10

51.6

2.60 (1.71-3.95)^c

39.7

2.28 (1.67-3.12)^c

11-27

53.3

2.82 (2.10-3.77)^c

45.6

2.72 (1.90-3.90)^c

0

33.1

1.00

24.8

1.00

1-2

49.8

2.07 (1.33-3.21)^b

33.1

1.46 (1.09-1.97)^a

3-5

54.3

2.71 (1.72-4.27)^c

37.6

1.81 (1.28-2.57)^b

6-8

64.5

4.50 (3.16-6.41)^c

43.7

2.21 (1.42-3.43)^c

9-10

64.1

4.09 (2.48-6.74)^c

62.8

5.41 (3.75-7.79)^c

11-27

68.2

5.26 (3.25-8.52)^c

58.8

4.36 (2.93-6.47)^c

0

13.0

1.00

13.9

1.00

1-2

22.0

1.95 (1.38-2.76)^c

15.4

1.16 (0.69-1.97)

3-5

23.8

2.24 (1.52-3.31)^c

18.6

1.42 (0.87-2.31)

6-8

32.0

3.46 (2.27-5.27)^c

27.0

2.30 (1.11-4.77)^a

9-10

39.1

4.54 (2.12-9.72)^c

29.5

2.60 (1.34-5.04)^b

11-27

33.6

3.74 (2.22-6.30)^c

29.4

2.51 (1.53-4.11)^c

0

28.3

1.00

21.6

1.00

1-2

40.6

1.79 (1.41-2.27)^c

29.4

1.52 (1.02-2.24)^a

3-5

45.5

2.28 (1.94-2.69)^c

34.0

1.90 (1.43-2.53)^c

6-8

51.2

3.05 (2.11-4.40)^c

39.2

2.26 (1.54-3.33)^c

9-10

62.5

4.63 (3.35-6.40)^c

39.7

2.50 (1.61-3.87)^c

11-27

61.7

4.59 (2.59-8.15)^c

49.4

3.43 (2.24-5.27)^c

0

27.5

1.00

17.9

1.00

1-2

29.8

1.12 (0.76-1.64)

17.1

0.96 (0.58-1.59)

3-5

31.3

1.24 (0.81-1.89)

28.5

1.82 (1.28-2.59)^b

6-8

37.4

1.68 (1.30-2.16)^c

36.5

2.62 (1.61-4.27)^c

9-10

45.3

2.25 (1.57-3.24)^c

43.6

3.56 (2.12-5.96)^c

11-27

40.6

1.90 (1.15-3.14)^a

37.5

2.79 (1.76-4.43)^c

0

14.1

1.00

10.9

1.00

1-2

18.0

1.36 (0.89-2.07)

16.3

1.59 (1.09-2.32)^a

3-5

23.4

1.83 (1.40-2.39)^c

16.6

1.67 (0.77-3.65)

6-8

34.3

3.21 (2.38-4.32)^c

21.6

2.28 (1.34-3.89)^b

9-10

40.6

4.04 (2.59-6.31)^c

35.9

4.65 (2.05-10.51)^c

11-27

37.4

3.69 (2.49-5.45)^c

31.3

3.70 (2.38-5.74)^c

0

4.5

1.00

8.4

1.00

1-2

7.1

1.66 (0.98-2.82)

9.1

1.12 (0.65-1.92)

3-5

9.4

2.43 (1.38-4.28)^b

9.5

1.18 (0.57-2.44)

6-8

11.8

3.28 (1.41-7.62)^b

7.9

0.96 (0.49-1.90)

9-10

17.2

4.65 (1.69-12.79)^b

20.5

2.91 (1.44-5.89)^b

11-27

14.0

4.10 (2.25-7.44)^c

21.9

3.08 (1.89-5.02)^c